Literature DB >> 20488909

The utility of diffusion-weighted imaging for cholesteatoma evaluation.

K M Schwartz1, J I Lane, B D Bolster, B A Neff.   

Abstract

DWI is a useful technique for the evaluation of cholesteatomas. It can be used to detect them when the physical examination is difficult and CT findings are equivocal, and it is especially useful in the evaluation of recurrent cholesteatoma. Initial DWI techniques only detected larger cholesteatomas, >5 mm, due to limitations of section thickness and prominent skull base artifacts. Newer techniques allow detection of smaller lesions and may be sufficient to replace second-look surgery in patients with prior cholesteatoma resection.

Entities:  

Mesh:

Year:  2010        PMID: 20488909      PMCID: PMC8013107          DOI: 10.3174/ajnr.A2129

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  32 in total

1.  Diffusion-weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma.

Authors:  Frederique Dubrulle; Raphaelle Souillard; David Chechin; François M Vaneecloo; Alain Desaulty; Christophe Vincent
Journal:  Radiology       Date:  2005-11-22       Impact factor: 11.105

2.  Usefulness of delayed postcontrast magnetic resonance imaging in the detection of residual cholesteatoma after canal wall-up tympanoplasty.

Authors:  D Ayache; M T Williams; D Lejeune; A Corré
Journal:  Laryngoscope       Date:  2005-04       Impact factor: 3.325

3.  Diffusion weighted imaging: a comprehensive evaluation of a fast spin echo DWI sequence with BLADE (PROPELLER) k-space sampling at 3 T, using a 32-channel head coil in acute brain ischemia.

Authors:  Ulrike I Attenberger; Val M Runge; Alto Stemmer; Kenneth D Williams; L Gill Naul; Henrik J Michaely; Stefan O Schoenberg; Maximilian F Reiser; Bernd J Wintersperger
Journal:  Invest Radiol       Date:  2009-10       Impact factor: 6.016

4.  Tympanoplasty: review of 400 staged cases.

Authors:  C Shelton; J L Sheehy
Journal:  Laryngoscope       Date:  1990-07       Impact factor: 3.325

Review 5.  Diffusion-weighted MR imaging of the brain.

Authors:  P W Schaefer; P E Grant; R G Gonzalez
Journal:  Radiology       Date:  2000-11       Impact factor: 11.105

6.  Residue of middle ear cholesteatoma after intact canal wall tympanoplasty: surgical findings at one year.

Authors:  K Gyo; Y Sasaki; Y Hinohira; N Yanagihara
Journal:  Ann Otol Rhinol Laryngol       Date:  1996-08       Impact factor: 1.547

7.  Comparison of echo-planar diffusion-weighted imaging and delayed postcontrast T1-weighted MR imaging for the detection of residual cholesteatoma.

Authors:  F Venail; A Bonafe; V Poirrier; M Mondain; A Uziel
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-16       Impact factor: 3.825

8.  The value of diffusion-weighted MR imaging in the diagnosis of primary acquired and residual cholesteatoma: a surgical verified study of 100 patients.

Authors:  Jean-Philippe Vercruysse; Bert De Foer; Marc Pouillon; Thomas Somers; Jan Casselman; Erwin Offeciers
Journal:  Eur Radiol       Date:  2006-03-03       Impact factor: 5.315

Review 9.  Biology of cholesteatoma.

Authors:  L Michaels
Journal:  Otolaryngol Clin North Am       Date:  1989-10       Impact factor: 3.346

10.  MRI, not CT, to rule out recurrent cholesteatoma and avoid unnecessary second-look mastoidectomy.

Authors:  Lela Migirov; Sigal Tal; Ana Eyal; Jona Kronenberg
Journal:  Isr Med Assoc J       Date:  2009-03       Impact factor: 0.892

View more
  27 in total

Review 1.  Imaging of skull base pathologies: Role of advanced magnetic resonance imaging techniques.

Authors:  Ankit Mathur; Narendra Jain; C Kesavadas; Bejoy Thomas; T R Kapilamoorthy
Journal:  Neuroradiol J       Date:  2015-10-01

Review 2.  "Dazed and diffused": making sense of diffusion abnormalities in neurologic pathologies.

Authors:  K M O'Connor; G Barest; T Moritani; O Sakai; A Mian
Journal:  Br J Radiol       Date:  2013-10-28       Impact factor: 3.039

3.  Quantitative evaluation of diffusion-weighted imaging techniques for the purposes of radiotherapy planning in the prostate.

Authors:  G P Liney; L Holloway; T M Al Harthi; M Sidhom; D Moses; E Juresic; R Rai; D J Manton
Journal:  Br J Radiol       Date:  2015-03-05       Impact factor: 3.039

Review 4.  Role of diffusion-weighted imaging in skull base lesions: A pictorial review.

Authors:  Neetu Soni; Nishant Gupta; Yogesh Kumar; Manisha Mangla; Rajiv Mangla
Journal:  Neuroradiol J       Date:  2017-06-20

5.  Computed tomography and magnetic resonance fusion imaging in cholesteatoma preoperative assessment.

Authors:  Agustín Campos; Federico Mata; Rosa Reboll; María Luisa Peris; Jorge Basterra
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-05       Impact factor: 2.503

Review 6.  Boba sign: a novel sign for floating balls within a mature cystic teratoma.

Authors:  Annalice Y Chang; Derek C Sun; Michael A Ohliger; Talib Abuzahriyeh; Hailey H Choi
Journal:  Abdom Radiol (NY)       Date:  2020-07-12

7.  Rapid diffusion-weighted MRI for the investigation of recurrent temporal bone cholesteatoma.

Authors:  Richard G Kavanagh; Stephen Liddy; Anne G Carroll; Yvonne M Purcell; Anna E Smyth; S Guan Khoo; Graeme McNeill; Dermot E Malone; Ronan P Killeen
Journal:  Neuroradiol J       Date:  2020-04-27

8.  Congenital Cholesteatoma in Adults-Interesting Presentations and Management.

Authors:  Priyanka Misale; Anjali Lepcha
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-13

9.  The diagnostic accuracy of non-echo-planar diffusion-weighted imaging in the detection of residual and/or recurrent cholesteatoma of the temporal bone.

Authors:  M H G Dremmen; P A M Hofman; J R Hof; R J Stokroos; A A Postma
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

10.  Use of non-echo-planar diffusion-weighted MR imaging for the detection of cholesteatomas in high-risk tympanic retraction pockets.

Authors:  A Alvo; C Garrido; Á Salas; G Miranda; C E Stott; P H Delano
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-08       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.